Related Experiment Video
Updated: Dec 24, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus
Kavina Shah1, Andrew Porter2, Gagandeep Takhar2
1Rheumatology Department, West Middlesex University Hospital NHS Trust, London, UK kavina.shah@ucl.ac.uk.
Abstract:
This report highlights the importance of tailored treatment strategies in severe systemic lupus erythematosus (SLE) flares driving the life-threatening condition, macrophage activation syndrome (MAS). We report the case of a 42-year-old woman with active systemic lupus erythematosus (SLE) who was diagnosed with MAS within 3 days of onset of lethargy, rash, joint pain and significant cytopenias. This early diagnosis meant that her condition was managed with less intensive immunosuppression with only modest doses of steroids and mycophenolate mofetil.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

